About Akums Lifesciences Limited
Data last updated:
Akums Lifesciences Limited was a public limited company based in Chandigarh, India, operated as a subsidiary of Akums Drugs And Pharmaceuticals Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 22 February 1996.
The company was registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231CH1996PLC017755. Its GSTIN is 04AACCP1419K2ZM (Chandigarh).
The company had an authorised share capital of ₹1,522 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Parabolic Drugs Limited. It was led by directors Himanshu Umeshbabu Saxena (Whole-Time Director) and Dharamvir Malik.
Its last annual general meeting (AGM) was held on 18 June 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at 2nd Floor SCO No. 144 – 145, Sector – 34A Chandigarh, Chandigarh, India – 160022.
As per the financials filed for FY 2023, the company reported a revenue of ₹222.57 Cr, a growth of 60% compared to the previous year. For the same year it recorded a net loss of ₹161.4 Cr (net margin -72.5%) and EBITDA of -₹104.19 Cr (EBITDA margin -46.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over five years.
The company had about 412 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Akums. As per MCA filings, the company had satisfied charges of ₹4,588.67 Cr on record. Court records list 125 cases involving the company, including 50 filed by the company and 76 filed against it; 17 cases are pending. The company has 15 deals on record (8 market trades, 3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹58.15 Cr; the latest was in February 2021. Its 6 peer companies in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is A. R. Life Sciences Private Limited with revenue of ₹229.48 Cr.
The last known website on record is akumslifesciences.com.
Company details
CIN history
Akums Lifesciences has one previous CIN (Corporate Identification Number): L24231CH1996PLC017755. The current CIN is U24231CH1996PLC017755, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231CH1996PLC017755 | Current |
| L24231CH1996PLC017755 | Previous |
Contact details
Akums Lifesciences Limited's registered office is in Chandigarh, Chandigarh. Its website is akumslifesciences.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address2nd Floor SCO No. 144 – 145, Sector – 34A Chandigarh, Chandigarh, India – 160022
- IndustryPharma, API Manufacturers
To see the full contact details of Akums Lifesciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Akums Lifesciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Akums Lifesciences Limited, buy the company report.
Financials of Akums Lifesciences Limited
FY 2023 filings availableAkums Lifesciences Limited reported revenue of ₹222.57 Cr (up 60% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 60% growth in the latest year. EBITDA fell 366% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹222.57 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹104.19 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹161.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -46.8% | ||||
| Net Profit Margin | -72.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akums Lifesciences Limited, buy the company report.
Board of directors and KMP of Akums Lifesciences Limited
Akums Lifesciences Limited currently reports 2 directors and 1 key managerial person. 33 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dharamvir Malik | Director | 31 Mar 2021 | 5 Years 7 Months | As last reported |
| Himanshu Umeshbabu Saxena Also directs: Sisha Pharma India Private Limited | Whole-Time Director | 13 Feb 2023 | 3 Years 8 Months | As last reported |
| Rama Shanker Also directs: Amazing Research Laboratories Limited | Cfo | 02 Mar 2020 | 6 Years 8 Months | As last reported |
Peer comparison
Akums Lifesciences Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| A. R. Life Sciences Private Limited | ₹229.48 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Loxim Industries Limited | ₹227.28 Cr (FY 2025) | 26.0% | Ahmedabad, Gujarat, India | |||
| Zeon Lifesciences Limited | ₹226.25 Cr (FY 2025) | 1.0% | Himachal Pradesh, India | |||
| Akums Lifesciences Limitedthis company | ₹222.57 Cr (FY 2023) | -₹161.4 Cr | -72.5% | 60.0% | 412 | Chandigarh, India |
| Vardhman Chemtech Limited | ₹208.69 Cr (FY 2025) | -13.0% | Chandigarh, India | |||
| Aktinos Pharma Private Limited | ₹207.85 Cr (FY 2024) | 18.0% | Hyderabad, Telangana, India | |||
| Nifty Labs Private Limited | ₹206.98 Cr (FY 2025) | 30.0% | Aran Road, Ameerpet, Hyd-016, Telangana, India |
To see the full peer comparison of Akums Lifesciences Limited, buy the company report.
Auditor
Akums Lifesciences Limited is audited by WALKER CHANDIOK & CO LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| WALKER CHANDIOK & CO LLP | FY 2023 | 001076N |
Shareholding
The shareholding of Akums Lifesciences Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Akums Lifesciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Apr 2013 | 10424936 | Sbicap Trustee Company Limited | ₹943.75 Cr | Satisfied | |
| 23 Apr 2013 | 10425242 | Sbicap Trustee Company Limited | ₹943.75 Cr | Satisfied | |
| 17 Aug 2012 | 10370431 | Others | ₹15 Cr | Satisfied | |
| 28 Dec 2011 | 10326822 | Export-Import Bank of India | ₹30 Cr | Satisfied | |
| 22 Dec 2011 | 10331192 | Others | ₹18 Cr | Satisfied |
To see the full charge records of Akums Lifesciences Limited, buy the company report.
Total charge records: 71 View all charges
Deals & funding
Akums Lifesciences Limited has 15 deals on record (8 market trades, 3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹58.15 Cr; the latest was in February 2021.
Deals on record (5 of 15)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2021 | Acquisition | ₹114.95 Cr | Buyer: Akums Drugs and Pharmaceuticals Limited |
| Jul 2016 | Market trade | ₹48.4 Lakh | Buyer: NBN Fintrade Private Limited , B M Traders Seller: NBN Fintrade Private Limited , B M Traders |
| Sep 2010 | Market trade | ₹8.14 Cr | Buyer: Alchemist Holdings Limited |
| Jul 2010 | Market trade | ₹13.7 Cr | Buyer: Crosseas Capital Markets Private Limited , Opg Securities Private Limited , Indea Long Term Opportunities Master Fund Seller: Crosseas Capital Markets Private Limited , Opg Securities Private Limited |
| Jul 2010 | Market trade | ₹12.64 Cr | Buyer: Crosseas Capital Markets Private Limited , Indea Long Term Opportunities Master Fund Seller: Crosseas Capital Markets Private Limited , Icici Bank Ltd. (Trading) |
To see the full deal history of Akums Lifesciences Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Akums Lifesciences Limited has 125 court cases on record: 50 filed by Akums Lifesciences, 76 filed against it. 17 cases are pending and 108 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 75 | 39 | 10 |
| High courts | 30 | 21 | 6 |
| NCLAT | 11 | 11 | 1 |
| NCLT | 6 | 2 | 0 |
| Supreme Court | 3 | 3 | 0 |
Cases on record (5 of 125)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Court case (CHAMBER SUMMONS) | Filed against the company by M/S. Sanjay Chemicals (India) Pvt. Ltd. Through Its Authorized Person Saseedharan M Velayudhan | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by Sanjay Chemicals (India) Pvt. Ltd. | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS) | Filed against the company by M/S. P. K. Pharmatech Pvt. Ltd. | Pending |
| Supreme Court | Appeal | Filed against the company by Punjab State Power Corporation Limited | Disposed |
| District court, Chandigarh | Criminal miscellaneous application | Filed by the company against Cecil Pharmaceuticals Pvt Ltd | Disposed |
To see the full case history of Akums Lifesciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akums Lifesciences Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Akums Lifesciences Limited has a workforce of 412 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
GST
Akums Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AACCP1419K2ZM | Chandigarh | Active | 15 Oct 2021 |
To see the full GST registrations and return filing status of Akums Lifesciences Limited, buy the company report.
Recent activity
Akums Lifesciences Limited has 34 board changes on record since 2007: 3 appointments and 31 cessations. The latest: Himanshu Umeshbabu Saxena ceased to be Additional Director on 17 Jun 2023.
205 earlier events are in the company report.
Frequently asked questions
Akums Lifesciences has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Akums Lifesciences was a public limited company based in Chandigarh, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 22 February 1996 and is registered under CIN U24231CH1996PLC017755. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Akums Lifesciences was incorporated on 22 February 1996. It is registered with the Registrar of Companies, Chandigarh.
Akums Lifesciences had 3 directors and KMP:
- Himanshu Umeshbabu Saxena - Whole-Time Director
- Dharamvir Malik - Director
- Rama Shanker - Cfo
The CIN (Corporate Identification Number) of Akums Lifesciences is U24231CH1996PLC017755. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Akums Lifesciences is at 2nd Floor SCO No. 144 – 145, Sector – 34A Chandigarh, Chandigarh, India – 160022.
Akums Lifesciences can be reached through the website akumslifesciences.com. Its registered office is in Chandigarh, India.
The latest financial statements of Akums Lifesciences on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 18 June 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Akums Lifesciences is 04AACCP1419K2ZM, registered in Chandigarh.
Akums Lifesciences operated in the pharma industry, in the api manufacturers segment.
Akums Lifesciences has 15 deals on record (8 market trades, 3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹58.15 Cr; the latest was in February 2021.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
